IAP inhibitors enhance co-stimulation to promote tumor immunity

Journal of Experimental Medicine

Volumn 207, Issue 10, 2010, Pages 2195-2206

  Dougan, Michael ^a   Dougan, Stephanie ^a,g   Slisz, Joanna ^b   Firestone, Brant ^b   Vanneman, Matthew ^a   Draganov, Dobrin ^a   Goyal, Girija ^a   Li, Weibo ^c,d   Neuberg, Donna ^e,f   Blumberg, Richard ^a   Hacohen, Nir ^c,d   Porter, Dale ^b   Zawel, Leigh ^b   Dranoff, Glenn ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR VACCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; TUMOR VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER PREVENTION; CD4+ T LYMPHOCYTE; CELL FUNCTION; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; HUMANS; IMMUNOMODULATION; INHIBITOR OF APOPTOSIS PROTEINS; MICE; NEOPLASMS; NF-KAPPA B; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957729423     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20101123     Document Type: Article

References (45)

1. Bauler, L.D., C.S. Duckett, and M.X. O'Riordan. 2008. XIAP regulates cytosol-specific innate immunity to Listeria infection. PLoS Pathog. 4:e1000142.
2. Bertrand, M.J., S. Milutinovic, K.M. Dickson, W.C. Ho, A. Boudreault, J. Durkin, J.W. Gillard, J.B. Jaquith, S.J. Morris, and P.A. Barker. 2008. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell. 30:689-700. doi:10.1016/j.molcel.2008. 05.014
3. Bertrand, M.J., K. Doiron, K. Labbé, R.G. Korneluk, P.A. Barker, and M. Saleh. 2009. Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity. 30:789-801. doi:10.1016/j.immuni.2009.04.011
4. Bidère, N., H.C. Su, and M.J. Lenardo. 2006. Genetic disorders of programmed cell death in the immune system. Annu. Rev. Immunol. 24:321-352. doi:10.1146/annurev.immunol.24.021605.090513
5. Conte, D., M. Holcik, C.A. Lefebvre, E. Lacasse, D.J. Picketts, K.E. Wright, and R.G. Korneluk. 2006. Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival. Mol. Cell. Biol. 26:699-708. doi:10.1128/MCB.26.2.699-708.2006 (Pubitemid 43090921)
6. Conze, D.B., L. Albert, D.A. Ferrick, D.V. Goeddel, W.C. Yeh, T. Mak, and J.D. Ashwell. 2005. Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol. Cell. Biol. 25:3348-3356. doi:10.1128/MCB.25.8.3348-3356.2005
7. Csomos, R.A., C.W. Wright, S. Galbán, K.A. Oetjen, and C.S. Duckett. 2009. Two distinct signalling cascades target the NF-kappaB regulatory factor c-IAP1 for degradation. Biochem. J. 420:83-91. doi:10.1042/BJ20082140
8. Diez, E., S.H. Lee, S. Gauthier, Z. Yaraghi, M. Tremblay, S. Vidal, and P. Gros. 2003. Birc1e is the gene within the Lgn1 locus associated with resistance to Legionella pneumophila. Nat. Genet. 33:55-60. doi:10.1038/ng1065 (Pubitemid 36068682)
9. Dougan, M., and G. Dranoff. 2009. Immune therapy for cancer. Annu. Rev. Immunol. 27:83-117. doi:10.1146/annurev.immunol.021908.132544
10. Dranoff, G., E. Jaffee, A. Lazenby, P. Golumbek, H. Levitsky, K. Brose, V. Jackson, H. Hamada, D. Pardoll, and R.C. Mulligan. 1993. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA. 90:3539-3543. doi:10.1073/pnas.90.8.3539 (Pubitemid 23111402)
11. Fontenot, J.D., J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 22:329-341. doi:10.1016/j.immuni.2005.01. 016
12. Gaither, A., D. Porter, Y. Yao, J. Borawski, G. Yang, J. Donovan, D. Sage, J. Slisz, M. Tran, C. Straub, et al. 2007. A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factoralpha signaling. Cancer Res. 67:11493-11498. doi:10.1158/0008-5472.CAN-07-5173
13. Greenwald, R.J., G.J. Freeman, and A.H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23:515-548. doi:10.1146/annurev.immunol.23. 021704.115611
14. Heemels, M.T., and H. Ploegh. 1995. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64:463-491. doi:10.1146/annurev.bi.64.070195.002335
15. Hogquist, K.A., S.C. Jameson, W.R. Heath, J.L. Howard, M.J. Bevan, and F.R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell. 76:17-27. doi:10.1016/0092-8674(94)90169-4 (Pubitemid 24035278)
16. Hu, S., M.Q. Du, S.M. Park, A. Alcivar, L. Qu, S. Gupta, J. Tang, M. Baens, H. Ye, T.H. Lee, et al. 2006. cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas. J. Clin. Invest. 116:174-181. doi:10.1172/JCI25641
17. Ishimaru, N., H. Kishimoto, Y. Hayashi, and J. Sprent. 2006. Regulation of naive T cell function by the NF-kappaB2 pathway. Nat. Immunol. 7:763-772. doi:10.1038/ni1351 (Pubitemid 43905876)
18. Jinushi, M., Y. Nakazaki, M. Dougan, D.R. Carrasco, M. Mihm, and G. Dranoff. 2007. MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF. J. Clin. Invest. 117:1902-1913. doi:10.1172/JCI30966 (Pubitemid 47036324)
19. Jost, P.J., S. Grabow, D. Gray, M.D. McKenzie, U. Nachbur, D.C. Huang, P. Bouillet, H.E. Thomas, C. Borner, J. Silke, et al. 2009. XIAP discriminates between type I and type II FAS-induced apoptosis. Nature. 460:1035-1039. doi:10.1038/nature08229
20. Karin, M., and A. Lin. 2002. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3:221-227. doi:10.1038/ni0302-221
21. Krieg, A., R.G. Correa, J.B. Garrison, G. Le Negrate, K. Welsh, Z. Huang, W.T. Knoefel, and J.C. Reed. 2009. XIAP mediates NOD signaling via interaction with RIP2. Proc. Natl. Acad. Sci. USA. 106:14524-14529. doi:10.1073/pnas. 0907131106
22. Leulier, F., N. Lhocine, B. Lemaitre, and P. Meier. 2006. The Drosophila inhibitor of apoptosis protein DIAP2 functions in innate immunity and is essential to resist gram-negative bacterial infection. Mol. Cell. Biol. 26:7821-7831. doi:10.1128/MCB.00548-06
23. Lu, M., S.C. Lin, Y. Huang, Y.J. Kang, R. Rich, Y.C. Lo, D. Myszka, J. Han, and H. Wu. 2007. XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol. Cell. 26:689-702. doi:10.1016/j.molcel. 2007.05.006 (Pubitemid 46856243)
24. Mahoney, D.J., H.H. Cheung, R.L. Mrad, S. Plenchette, C. Simard, E. Enwere, V. Arora, T.W. Mak, E.C. Lacasse, J. Waring, and R.G. Korneluk. 2008. Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc. Natl. Acad. Sci. USA. 105:11778-11783. doi:10.1073/pnas.0711122105
25. Marsh, R.A., J. Villanueva, M.O. Kim, K. Zhang, D. Marmer, K.A. Risma, M.B. Jordan, J.J. Bleesing, and A.H. Filipovich. 2009. Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations. Clin. Immunol. 132:116-123. doi:10.1016/j.clim.2009. 03.517
26. Matsuzawa, A., P.H. Tseng, S. Vallabhapurapu, J.L. Luo, W. Zhang, H. Wang, D.A. Vignali, E. Gallagher, and M. Karin. 2008. Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science. 321:663-668. doi:10.1126/science.1157340
27. Miyawaki, S., Y. Nakamura, H. Suzuka, M. Koba, R. Yasumizu, S. Ikehara, and Y. Shibata. 1994. A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur. J. Immunol. 24:429-434. doi:10.1002/eji.1830240224 (Pubitemid 24041135)
28. Moffat, J., D.A. Grueneberg, X. Yang, S.Y. Kim, A.M. Kloepfer, G. Hinkle, B. Piqani, T.M. Eisenhaure, B. Luo, J.K. Grenier, et al. 2006. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell. 124:1283-1298. doi:10.1016/j.cell.2006.01.040
29. Petersen, S.L., L. Wang, A. Yalcin-Chin, L. Li, M. Peyton, J. Minna, P. Harran, and X. Wang. 2007. Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell. 12:445-456. doi:10.1016/j.ccr.2007.08.029
30. Raulet, D.H., R.E. Vance, and C.W. McMahon. 2001. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19:291-330. doi:10.1146/annurev.immunol.19.1.291 (Pubitemid 32368038)
31. Rigaud, S., M.C. Fondanèche, N. Lambert, B. Pasquier, V. Mateo, P. Soulas, L. Galicier, F. Le Deist, F. Rieux-Laucat, P. Revy, et al. 2006. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 444:110-114. doi:10.1038/nature05257
32. Rumble, J.M., K.A. Oetjen, P.L. Stein, P.L. Schwartzberg, B.B. Moore, and C.S. Duckett. 2009. Phenotypic differences between mice deficient in XIAP and SAP, two factors targeted in X-linked lymphoproliferative syndrome (XLP). Cell. Immunol. 259:82-89. doi:10.1016/j.cellimm.2009.05.017
33. Schile, A.J., M. García-Fernández, and H. Steller. 2008. Regulation of apoptosis by XIAP ubiquitin-ligase activity. Genes Dev. 22:2256-2266. doi:10.1101/gad.1663108
34. Shinkura, R., K. Kitada, F. Matsuda, K. Tashiro, K. Ikuta, M. Suzuki, K. Kogishi, T. Serikawa, and T. Honjo. 1999. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. Nat. Genet. 22:74-77. doi:10.1038/8780
35. Srinivasula, S.M., and J.D. Ashwell. 2008. IAPs: what's in a name? Mol. Cell. 30:123-135. doi:10.1016/j.molcel.2008.03.008
36. Vallabhapurapu, S., A. Matsuzawa, W. Zhang, P.H. Tseng, J.J. Keats, H. Wang, D.A. Vignali, P.L. Bergsagel, and M. Karin. 2008. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat. Immunol. 9:1364-1370. doi:10.1038/ni.1678
37. Varfolomeev, E., J.W. Blankenship, S.M. Wayson, A.V. Fedorova, N. Kayagaki, P. Garg, K. Zobel, J.N. Dynek, L.O. Elliott, H.J. Wallweber, et al. 2007. IAP antagonists induce autoubiquitination of c-IAPs, NFkappaB activation, and TNFalpha-dependent apoptosis. Cell. 131:669-681. doi:10.1016/j.cell.2007.10. 030
38. Varfolomeev, E., T. Goncharov, A.V. Fedorova, J.N. Dynek, K. Zobel, K. Deshayes, W.J. Fairbrother, and D. Vucic. 2008. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J. Biol. Chem. 283:24295-24299. doi:10.1074/jbc.C800128200
39. Vince, J.E., W.W. Wong, N. Khan, R. Feltham, D. Chau, A.U. Ahmed, C.A. Benetatos, S.K. Chunduru, S.M. Condon, M. McKinlay, et al. 2007. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell. 131:682-693. doi:10.1016/j.cell.2007.10.037
40. Vince, J.E., D. Chau, B. Callus, W.W. Wong, C.J. Hawkins, P. Schneider, M. McKinlay, C.A. Benetatos, S.M. Condon, S.K. Chunduru, et al. 2008. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFα. J. Cell Biol. 182:171-184. doi:10.1083/jcb.200801010
41. Wang, L., F. Du, and X. Wang. 2008. TNF-alpha induces two distinct caspase-8 activation pathways. Cell. 133:693-703. doi:10.1016/j.cell.2008.03.036 (Pubitemid 351636305)
42. Watts, T.H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23:23-68. doi:10.1146/annurev.immunol.23.021704. 115839 (Pubitemid 40563164)
43. Xu, L., J. Zhu, X. Hu, H. Zhu, H.T. Kim, J. LaBaer, A. Goldberg, and J. Yuan. 2007. c-IAP1 cooperates with Myc by acting as a ubiquitin ligase for Mad1. Mol. Cell. 28:914-922. doi:10.1016/j.molcel.2007.10.027 (Pubitemid 350217057)
44. Yang, Y.L., and X.M. Li. 2000. The IAP family: endogenous caspase inhibitors with multiple biological activities. Cell Res. 10:169-177. doi:10.1038/sj.cr.7290046
45. Zarnegar, B.J., Y. Wang, D.J. Mahoney, P.W. Dempsey, H.H. Cheung, J. He, T. Shiba, X. Yang, W.C. Yeh, T.W. Mak, et al. 2008. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol. 9:1371-1378. doi:10.1038/ni.1676